- Investing Ideas
- Japanese Biotech Breakthroughs
Japanese Biotech Breakthroughs
Results
3
0 new
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
3 companies
GNI Group
Market Cap: JP¥176.5b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥3,165.00
7D
-6.6%
1Y
38.7%
Healios K.K
Market Cap: JP¥43.5b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥322.00
7D
-13.2%
1Y
0.6%
SanBio
Market Cap: JP¥154.3b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system.
4592
JP¥1,977.00
7D
-9.3%
1Y
-2.0%